Abstract
Background/Aims
Small bowel capsule endoscopy (SBCE) is used to visualize mucosal inflammatory changes in the small intestine of patients with Crohn’s disease (CD). The Lewis score (LS) and Capsule Endoscopy Crohn’s Disease Activity Index (CECDAI) are used to evaluate the visualized images. We determined the score disagreement between LS and CECDAI in patients with CD.
Methods
We evaluated 184 SBCE procedures in 102 CD patients with small bowel lesions. Patients were classified according to the Montreal classification. LS and CECDAI were calculated, and cases with disagreement between the two scores were identified. We investigated the characteristics of disagreement, and analyzed the relationships with the Crohn’s Disease Activity Index (CDAI) and C-reactive protein.
Results
LS (504 ± 1160) correlated strongly with CECDAI (6 ± 5.4) (Spearman’s rank correlation coefficient ρ = 0.81, p < 0.0001). LS values of 135 and 790 were equivalent to CECDAI values of 4.9 and 6.9, respectively. The inflammatory changes by LS were significantly observed in several tertiles in the CECDAI discrepancy group (LS < 135, CECDAI ≥ 4.9) compared with the normal agreement group (LS < 135, CECDAI < 4.9) (p < 0.0001). In both groups, CDAI was also significantly different between Montreal L1 and L3 groups (p = 0.0232, p = 0.0196, respectively). LS inflammation score was 0 in six cases in the LS discrepancy group (LS ≥ 135, CECDAI ≤ 4.9, n = 10); the high LS scores were in patients with high stricture scores.
Conclusions
Discrepancies between the LS and CECDAI scores were observed in some patients. Cases with high CECDAI alone exhibited extensive inflammation and high disease activity (clinical symptoms and biomarker levels). CECDAI seems to better reflect active intestinal inflammation than LS.
Similar content being viewed by others
Abbreviations
- CD:
-
Crohn’s disease
- CDAI:
-
Crohn’s Disease Activity Index
- SBCE:
-
Small bowel capsule endoscopy
- CECDAI:
-
Capsule Endoscopy Crohn’s Disease Activity Index
- CRP:
-
C-reactive protein
- LS:
-
Lewis score
- PC:
-
Patency capsule
- SES-CD:
-
Simple Endoscopic Score for Crohn’s Disease
References
Pennazio M, Spada C, Eliakim R, et al. Small-bowel capsule endoscopy and device-assisted enteroscopy for diagnosis and treatment of small-bowel disorders: European Society of Gastrointestinal Endoscopy (ESGE) Clinical Guideline. Endoscopy. 2015;47:352–376.
Enns RA, Hookey L, Armstrong D, et al. Clinical practice guidelines for the use of video capsule endoscopy. Gastroenterology. 2017;152:497–514.
Bourreille A, Ignjatovic A, Aabakken L, et al. Role of small-bowel endoscopy in the management of patients with inflammatory bowel disease: an international OMED-ECCO consensus. Endoscopy. 2009;41:618–637.
Gomollón F, Dignass A, Annese V, et al. 3rd European evidence-based consensus on the diagnosis and management of Crohn’s Disease 2016: part 1: diagnosis and medical management. J Crohn’s Colitis. 2017;11:3–25.
Shergill AK, Lightdale JR, Bruining DH, et al. The role of endoscopy in inflammatory bowel disease. Gastrointest Endosc. 2015;81:1101–1121.
Annese V, Daperno M, Rutter MD, et al. European evidence based consensus for endoscopy in inflammatory bowel disease. J Crohn’s Colitis. 2013;7:982–1018.
Yamamoto H, Ogata H, Matsumoto T, et al. Clinical practice guideline for enteroscopy. Dig Endosc. 2017;29:519–546.
Gralnek IM, Defranchis R, Seidman E, et al. Development of a capsule endoscopy scoring index for small bowel mucosal inflammatory change. Aliment Pharmacol Ther. 2008;27:146–154.
Gal E, Geller A, Fraser G, et al. Assessment and validation of the new capsule endoscopy Crohn’s disease activity index (CECDAI). Dig Dis Sci. 2008;53:1933–1937. https://doi.org/10.1007/s10620-007-0084-y.
Yablecovitch D, Lahat A, Neuman S. The Lewis score or the capsule endoscopy Crohn’s disease activity index: Which one is better for the assessment of small bowel inflammation in established Crohn’s disease? Therap Adv Gastroenterol. 2018;11:1756283X17747780.
Ponte A, Pinho R, Rodrigues A. Evaluation and comparison of capsule endoscopy scores for assessment of inflammatory activity of small-bowel in Crohn’s disease. Gastroenterol Hepatol. 2018;41:245–250.
Koulaouzidis A, Douglas S, Plevris JN. Lewis score correlates more closely with fecal calprotectin than Capsule Endoscopy Crohn’s Disease Activity Index. Dig Dis Sci. 2012;57:987–993. https://doi.org/10.1007/s10620-011-1956-8.
Koulaouzidis A, Rondonotti E, Karargyris A. Small-bowel capsule endoscopy: a ten-point contemporary review. World J Gastroenterol. 2013;19:3726–3746.
Tukey M, Pleskow D, Legnani P, et al. The utility of capsule endoscopy in patients with suspected Crohn’s disease. Am J Gastroenterol. 2009;104:2734–2739.
Mow WS, Lo SK, Targan SR, et al. Initial experience with wireless capsule enteroscopy in the diagnosis and management of inflammatory bowel disease. Clin Gastroenterol Hepatol. 2004;2:31–40.
Leighton JA. The role of endoscopic imaging of the small bowel in clinical practice. Am J Gastroenterol. 2011;106:27–36.
Lewis BS, Eisen GM, Friedman S. A pooled analysis to evaluate results of capsule endoscopy trials. Endoscopy. 2005;37:960–965.
Kopylov U, Ben-Horin S, Seidman EG, et al. Video capsule endoscopy of the small bowel for monitoring of Crohn’s disease. Inflamm Bowel Dis. 2015;21:2726–2735.
Cotter J, Dias de Castro F, Moreira MJ, et al. Tailoring Crohn’s disease treatment: the impact of small bowel capsule endoscopy. J Crohn’s Colitis. 2014;8:1610–1615.
Santos-Antunes J, Cardoso H, Lopes S, et al. Capsule enteroscopy is useful for the therapeutic management of Crohn’s disease. World J Gastroenterol. 2015;21:12660–12666.
Cotter J, Dias de Castro F, Magalhães J, et al. Validation of the Lewis score for the evaluation of small-bowel Crohn’s disease activity. Endoscopy. 2015;47:330–335.
Niv Y, Ilani S, Levi Z, et al. Validation of the capsule endoscopy Crohn’s disease activity index (CECDAI or Niv score): a multicenter prospective study. Endoscopy. 2012;44:21–26.
Kopylov U, Yablecovitch D, Lahat A, et al. Detection of small bowel mucosal healing and deep remission in patients with known small bowel Crohn’s disease using biomarkers, capsule endoscopy, and imaging. Am J Gastroenterol. 2015;110:1316–1323.
Mitselos IV, Katsanos KH, Tatsioni A, et al. Association of clinical and inflammatory markers with small bowel capsule endoscopy findings in Crohn’s disease. Eur J Gastroenterol Hepatol. 2018;308:861–867.
Taleban S, Stewart KO, Li DK, et al. Clinical activity and quality of life indices are valid across ulcerative colitis but not Crohn’s disease phenotypes. Dig Dis Sci. 2016;61:2627–2635. https://doi.org/10.1007/s10620-016-4180-8.
Author information
Authors and Affiliations
Contributions
TO and SN: study concept and design. HK, SM, AI, MY and TO: data acquisition. TO: statistical analysis and drafting of the first version of the manuscript. TO, SN, and KT: critical revision and approval of the final version of the manuscript.
Corresponding author
Ethics declarations
Conflict of interest
The authors declare no conflict of interest.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Electronic supplementary material
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
Omori, T., Kambayashi, H., Murasugi, S. et al. Comparison of Lewis Score and Capsule Endoscopy Crohn’s Disease Activity Index in Patients with Crohn’s Disease. Dig Dis Sci 65, 1180–1188 (2020). https://doi.org/10.1007/s10620-019-05837-7
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10620-019-05837-7